Literature DB >> 11866739

Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia.

William R. Gransden1, Leonard Leibovici, Susannah J. Eykyn, Silvio D. Pitlik, Zmira Samra, Hanna Konisberger, Moshe Drucker, Ian Phillips.   

Abstract

OBJECTIVE: To define risk factors significantly and independently associated with Pseudomonas aeruginosa bacteremia and to combine them in a diagnostic index which will define groups of septic patients at low or high risk of bloodstream infection caused by P. aeruginosa.
METHODS: Logistic regression analysis was used to identify risk factors associated with pseudomonal bacteremia among all patients with bacteremia at St Thomas' Hospital, London, from 1969 to 1989. The coefficients of the final logistic model were used to compile a linear model for the diagnosis of pseudomonal bacteremia. The index was validated in another set of patients with bacteremia detected at Beilinson Medical Center, Petah Tiqva, Israel, from 1988 to 1991.
RESULTS: Seven factors were significantly and independently predictive of pseudomonal bacteremia: 1) neutropenia; 2) previous or current treatment with antibiotics; 3) cytotoxic or corticosteroid treatment; 4) hospital acquisition of infection; 5) detection in the intensive care unit; 6) male gender; and 7) focus of infection. High-risk foci were the urinary tract with catheter or post-instrumentation, or unknown source. Low-risk foci were bone, joint, meninges, female genital tract and upper respiratory tract. The index score divided patients into three groups with increasing likelihood of P. aeruginosa bacteremia: 1%, 7% and 19%, respectively (p=0.0001). In the validation set, the percentage of P. aeruginosa bacteremia in the three respective groups defined by the index were 5%, 18% and 22% (p=0.0001).
CONCLUSIONS: The use of simple clinical and laboratory data known within hours of detection of an infectious episode can define patients at high and low risk for P. aeruginosa bacteremia.

Entities:  

Year:  1995        PMID: 11866739     DOI: 10.1111/j.1469-0691.1995.tb00455.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  10 in total

1.  Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection.

Authors:  Sarah E Battle; Matthew R Augustine; Christopher M Watson; P Brandon Bookstaver; Joseph Kohn; William B Owens; Larry M Baddour; Majdi N Al-Hasan
Journal:  Infection       Date:  2019-02-08       Impact factor: 3.553

2.  Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.

Authors:  L Leibovici; M Paul; O Poznanski; M Drucker; Z Samra; H Konigsberger; S D Pitlik
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development-Results from the PRO-BAC Cohort.

Authors:  Pedro María Martínez Pérez-Crespo; Álvaro Rojas; Joaquín Felipe Lanz-García; Pilar Retamar-Gentil; José María Reguera-Iglesias; Olalla Lima-Rodríguez; Alfonso Del Arco Jiménez; Jonathan Fernández Suárez; Alfredo Jover-Saenz; Josune Goikoetxea Aguirre; Eva León Jiménez; María Luisa Cantón-Bulnes; Pilar Ortega Lafont; Carlos Armiñanzas Castillo; Juan Sevilla Blanco; Jordi Cuquet Pedragosa; Lucía Boix-Palop; Berta Becerril Carral; Alberto Bahamonde-Carrasco; Teresa Marrodan Ciordia; Clara Natera Kindelán; Isabel María Reche Molina; Carmen Herrero Rodríguez; Inés Pérez Camacho; David Vinuesa García; Fátima Galán-Sánchez; Alejandro Smithson Amat; Esperanza Merino de Lucas; Antonio Sánchez-Porto; Marcos Guzmán García; Inmaculada López-Hernández; Jesús Rodríguez-Baño; Luis Eduardo López-Cortés
Journal:  Antibiotics (Basel)       Date:  2022-05-24

4.  Identification of Potential Urinary Metabolite Biomarkers of Pseudomonas aeruginosa Ventilator-Associated Pneumonia.

Authors:  Bart's Jongers; An Hotterbeekx; Kenny Bielen; Philippe Vervliet; Jan Boddaert; Christine Lammens; Erik Fransen; Geert Baggerman; Adrian Covaci; Herman Goossens; Surbhi Malhotra-Kumar; Philippe G Jorens; Samir Kumar-Singh
Journal:  Biomark Insights       Date:  2022-05-13

Review 5.  Direct Measurement of Performance: A New Era in Antimicrobial Stewardship.

Authors:  Majdi N Al-Hasan; Hana Rac Winders; P Brandon Bookstaver; Julie Ann Justo
Journal:  Antibiotics (Basel)       Date:  2019-08-24

Review 6.  Advances in Understanding of the Copper Homeostasis in Pseudomonas aeruginosa.

Authors:  Lukas Hofmann; Melanie Hirsch; Sharon Ruthstein
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae.

Authors:  Ji Hwan Bang; Younghee Jung; Shinhye Cheon; Chung Jong Kim; Kyung Ho Song; Pyeong Gyun Choe; Wan Beom Park; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Myoung-don Oh; Hyo-Suk Lee; Nam Joong Kim
Journal:  BMC Infect Dis       Date:  2013-07-19       Impact factor: 3.090

8.  Pseudomonas bacteremia as an initial presentation of SLE.

Authors:  Veenu Gill; Jatinbhai Patel; Sanjana Koshy; Tessa Gomez
Journal:  IDCases       Date:  2014-09-16

9.  Prosthetic vascular graft infection and prosthetic joint infection caused by Pseudomonas stutzeri.

Authors:  Michael J Bonares; Alon Vaisman; Abdu Sharkawy
Journal:  IDCases       Date:  2016-11-04

Review 10.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.